<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Pharsight Corporation (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Pharsight+Corporation</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Pharsight+Corporation" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Mon, 27 Oct 2008 21:38:46 GMT</pubDate><lastBuildDate>Mon, 27 Oct 2008 21:38:46 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Pharsight Corporation (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Pharsight+Corporation</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Pharsight Stockholders Approve Acquisition by Tripos (GlobeNewswi...
      </title><link>http://biz.yahoo.com/pz/081027/153099.html</link><description>Pharsight Stockholders Approve Acquisition by Tripos. - MOUNTAIN VIEW, Calif., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News) today announced that its stockholders have approved the previously announced acquisition of Pharsight by Tripos.</description><guid>http://biz.yahoo.com/pz/081027/153099.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Mon, 27 Oct 2008 21:38:46 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Tripos to Acquire Pharsight Corporation for $57 Million</title><link>http://www.biospace.com/news_story.aspx?StoryID=109056&amp;full=1</link><description>ST. LOUIS and MOUNTAIN VIEW, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Tripos, a leading provider of drug discovery informatics products and services, and Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic, and regulatory services designed to optimize clinical</description><guid>http://www.biospace.com/news_story.aspx?StoryID=109056&amp;full=1</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 09 Sep 2008 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Pharsight to Present On Modeling and Simulation At 'Magic Bullets...
      </title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080930/151199.html</link><description>Pharsight to Present On Modeling and Simulation At 'Magic Bullets' to Treat Disease World Conference. - MOUNTAIN VIEW, Calif., Sept. 30, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for</description><guid>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080930/151199.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 30 Sep 2008 10:30:00 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>Tripos to Acquire Pharsight Corporation</title><link>http://www.dddmag.com/news-Tripos-to-Acquire-Pharsight-Corporation.aspx</link><description>Tripos and Pharsight Corporation announced they have entered into a definitive agreement for Pharsight to be acquired by Tripos for approximately $57 million in cash.</description><guid>http://www.dddmag.com/news-Tripos-to-Acquire-Pharsight-Corporation.aspx</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.dddmag.com" /></item><item><title>Pharsight Insights: Cephalon Expands Label Using Modeling and Sim...
      </title><link>http://www.pharsight.com/newsletter/winter2006/collaborationstrategydevelopment_0106.php</link><description>When Cephalon, Inc. (“Cephalon”) first set out to expand the label of its flagship compound, Provigil™, it needed a factual basis to support a go/no-go decision for a previously unstudied indication—quickly, efficiently, and with as much certainty as possible.</description><guid>http://www.pharsight.com/newsletter/winter2006/collaborationstrategydevelopment_0106.php</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.pharsight.com" /></item><item><title>Pharsight Corporation News - The New York Times</title><link>http://topics.nytimes.com/top/news/business/companies/pharsight-corporation/index.html</link><description>Error string returned: Get Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics Search All NYTimes.com New York Times Business World U.S. N.Y. / Region Business Technology Science Health Sports Opinion Arts Style Travel Jobs Real Estate Autos Search</description><guid>http://topics.nytimes.com/top/news/business/companies/pharsight-corporation/index.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://topics.nytimes.com" /></item><item><title>S-PLUS OEM Agreement Enhances Products and Services Available to ...
      </title><link>http://www.insightful.com/news_events/release.asp?RID=51</link><description>S-PLUS OEM Agreement Enhances Products and Services Available to Reduce Costs and Improve Efficiency of Clinical Trials SEATTLE, WA - February 8, 2000 - MathSoft, Inc.</description><guid>http://www.insightful.com/news_events/release.asp?RID=51</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.insightful.com" /></item><item><title>TechWeb: The Business Technology Network</title><link>http://www.techweb.com/showPressRelease.jhtml?articleID=X698118&amp;CompanyId=3</link><description>MOUNTAIN VIEW, Calif., May 27 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Helen Kastrissios, Ph.D.</description><guid>http://www.techweb.com/showPressRelease.jhtml?articleID=X698118&amp;CompanyId=3</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.techweb.com" /></item><item><title>Pharsight to Present On Modeling and Simulation At Spanish Pharma...
      </title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080915/150228.html</link><description>Pharsight to Present On Modeling and Simulation At Spanish Pharmacological Society Annual Meeting. - MOUNTAIN VIEW, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for optimizing</description><guid>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/080915/150228.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Mon, 15 Sep 2008 10:00:00 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>Pharsight to Present On QTc Modeling and Simulation At ACCP Annua...
      </title><link>http://biz.yahoo.com/pz/080911/150132.html</link><description>Pharsight to Present On QTc Modeling and Simulation At ACCP Annual Meeting. - MOUNTAIN VIEW, Calif., Sept. 11, 2008 (GLOBE NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug</description><guid>http://biz.yahoo.com/pz/080911/150132.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Thu, 11 Sep 2008 10:30:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Tripos to Acquire Pharsight Corporation (GlobeNewswire)</title><link>http://biz.yahoo.com/pz/080909/149950.html</link><description>Tripos is wholly owned by Vector Capital, a San Francisco-based private equity firm specializing in buyouts, spinouts and recapitalizations of established technology businesses. Under the terms of the agreement, Pharsight stockholders will receive $5.</description><guid>http://biz.yahoo.com/pz/080909/149950.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 09 Sep 2008 13:00:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Pharsight to Present At Noble Financial Fourth Annual Equity Conf...
      </title><link>http://biz.yahoo.com/pz/080811/148400.html</link><description>Pharsight to Present At Noble Financial Fourth Annual Equity Conference. - MOUNTAIN VIEW, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development,</description><guid>http://biz.yahoo.com/pz/080811/148400.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Mon, 11 Aug 2008 20:25:56 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Pharsight and CRI Worldwide Establish Alliance (PrimeNewswire)</title><link>http://biz.yahoo.com/pz/080722/146788.html</link><description>Pharsight and CRI Worldwide Establish Alliance. - MOUNTAIN VIEW, Calif., and CLEMENTON, N.J., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and</description><guid>http://biz.yahoo.com/pz/080722/146788.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 22 Jul 2008 10:40:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Pharsight to Present On Modeling and Simulation At Quebec CPT Wor...
      </title><link>http://biz.yahoo.com/pz/080722/146703.html</link><description>Pharsight to Present On Modeling and Simulation At Quebec CPT World Congress. - MOUNTAIN VIEW, Calif., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (NasdaqCM:PHST - News), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug</description><guid>http://biz.yahoo.com/pz/080722/146703.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 22 Jul 2008 10:30:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Pharsight Broadens Reporting and Analysis Services Offerings (Pri...
      </title><link>http://biz.yahoo.com/pz/080715/146367.html</link><description>Pharsight Broadens Reporting and Analysis Services Offerings. - New Offerings Include Preclinical, Biostatistics, Data Management Company Expands RAS Management Team</description><guid>http://biz.yahoo.com/pz/080715/146367.html</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate>Tue, 15 Jul 2008 10:30:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>VAR Agreement Will Enhance Products and Services for Pharmaceutic...
      </title><link>http://www.insightful.com/news_events/release.asp?RID=65</link><description>VAR Agreement Will Enhance Products and Services for Pharmaceutical, Biotechnology and Health Sciences Industries CAMBRIDGE, MA - March 29, 1999 - MathSoft, Inc.</description><guid>http://www.insightful.com/news_events/release.asp?RID=65</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.insightful.com" /></item><item><title>TechWeb: The Business Technology Network</title><link>http://www.techweb.com/showPressRelease.jhtml?articleID=X691970&amp;CompanyId=3</link><description>MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Bill Poland, Ph.D.</description><guid>http://www.techweb.com/showPressRelease.jhtml?articleID=X691970&amp;CompanyId=3</guid><category domain="http://www.zibb.com">Pharsight Corporation</category><pubDate /><source url="http://www.techweb.com" /></item></channel></rss>